John Haanen Honored with 2024 ESMO Lifetime Achievement Award

John Haanen was recently awarded the 2024 ESMO Lifetime Achievement Award.

John B.A.G. Haanen is a professor at the department of clinical oncology of the Leiden University Medical Center.

He is also the Head of the Division of Medical Oncology and Leader Research theme Immunotherapy at The Netherlands Cancer Institute in Amsterdam, The Netherlands.

Additionally, he is the Head of Melanoma Clinic at CHUV.

Dr. Haanen serves as Professor in translational immunotherapy of cancer at the Leiden University Medical Center.

John Haanen finished his MD at Leiden University cum laude in 1988.

From 1988 till 1991 he performed his PhD studies at the Division of Immunohematology and Blood Bank of Leiden University Medical Center and at DNAX, Research Institute, Palo Alto, California, US.

His research has been focused on the development of innovative immunotherapies in close collaboration with Ton Schumacher.

He has co-authored over 500 peer-reviewed articles, serves on the Editorial Board of ESMO Open, Cancer Treatment Reviews and Kidney Cancer. He is currently Editor-in-Chief of ESMO IOTECH.

ESMO congratulated John Haanen on social media:

“ Melanoma research continues to lead the way in the field of Immunooncology.

John Haanen is the recipient of the 2024 ESMO Lifetime Achievement Award for his ground-breaking work on Cancer Immunotherapy, from checkpoint inhibitors to cellular strategies.

He shares some of his highlights from a career full of innovation at ESMO24, recounting the dramatic improvements he has witnessed in the management of melanoma over the last 25 years.

And what is next?”

For more posts like this, visit oncodaily.com